Fairchem Organics Ltd AI Stock Analysis
Want to see IN:FAIRCHEMOR full AI Analyst Report?
Fairchem Organics Ltd (FAIRCHEMOR) AI Stock Analysis
Fairchem Organics Ltd
(NSE:FAIRCHEMOR)
The overall score is heavily weighed down by severe fundamental weaknesses and stretched valuations, despite exceptionally strong technical momentum. The most impactful risks are drastic margin erosion and a high P/E ratio, while positive price trends remain the primary supportive factor for the stock.
Fairchem Organics Ltd (FAIRCHEMOR) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 8.23B
- Dividend Yield
- 0.15%
- Average Volume (3M)
- 2,981
- Price to Earnings (P/E)
- 34.9
- Beta (1Y)
- 0.02
- Revenue Growth
- 17.44%
- EPS Growth
- 304.08%
- Country
- India
- Employees
- 212
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Fairchem Organics Ltd Business Overview & Revenue Model
Company Description
Fairchem Organics Limited, headquartered in Ahmedabad, India, was founded in 2019. This company specializes in the manufacturing and worldwide sale of sophisticated oleochemicals and key nutraceutical components. Its market reach extends across India...
Fairchem Organics Ltd Financial Statement Overview
Summary
Financial performance is significantly impaired by severe margin compression, ongoing revenue declines, and a plummeting Return on Equity. A recent return to positive cash generation and manageable debt levels provide some stabilization against these operational headwinds.
Income Statement
15Very NegativeBalance Sheet
48NeutralCash Flow
58Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.60B | 4.60B | 5.38B | 6.21B | 6.47B | 6.42B |
| Gross Profit | 642.92M | 355.37M | 666.52M | 1.54B | 1.56B | 1.78B |
| EBITDA | 446.72M | 220.40M | 441.21M | 681.10M | 729.68M | 1.05B |
| Net Income | 237.76M | 55.41M | 219.74M | 405.00M | 435.01M | 679.06M |
Balance Sheet | ||||||
| Total Assets | 3.98B | 3.91B | 4.02B | 3.34B | 3.42B | 3.24B |
| Cash, Cash Equivalents and Short-Term Investments | 14.24M | 12.26M | 12.86M | 84.00K | 838.00K | 83.00K |
| Total Debt | 702.35M | 837.82M | 630.32M | 73.18M | 501.68M | 620.30M |
| Total Liabilities | 1.17B | 1.28B | 997.98M | 443.77M | 831.48M | 919.26M |
| Stockholders Equity | 2.82B | 2.63B | 3.02B | 2.90B | 2.59B | 2.32B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 229.13M | -464.87M | 563.52M | 348.89M | 58.91M |
| Operating Cash Flow | 0 | 382.54M | -203.78M | 744.80M | 496.15M | 404.85M |
| Investing Cash Flow | 0 | -140.95M | -255.71M | -176.25M | -144.92M | -341.84M |
| Financing Cash Flow | 0 | -241.53M | 459.49M | -568.55M | -351.24M | -63.19M |
Fairchem Organics Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FAIRCHEMOR, the sentiment is Negative. The current price of 653.70 is below the 20-day moving average (MA) of 682.62, below the 50-day MA of 681.82, and above the 200-day MA of 638.77, indicating a neutral trend. The MACD of -9.65 indicates Positive momentum. The RSI at 43.98 is Neutral, neither overbought nor oversold. The STOCH value of 23.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:FAIRCHEMOR.
Fairchem Organics Ltd Peers Comparison
Overall Rating
IN:ATUL68Neutral
IN:ALKYLAMINE61Neutral
IN:JUBLINGREA61Neutral
IN:FAIRCHEMOR53Neutral
IN:AARTIIND47Neutral
IN:LXCHEM46Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 68Neutral | INR 149.07B | 19.31 | ― | 0.59% | 18.15% | 42.38% | |
| 61Neutral | INR 80.54B | 32.52 | ― | 0.64% | 13.38% | 35.82% | |
| 61Neutral | INR 91.41B | 25.83 | ― | 0.87% | 15.41% | 21.76% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | INR 8.23B | 34.94 | ― | 0.15% | 17.44% | 304.08% | |
| 47Neutral | INR 165.88B | 28.02 | ― | 0.22% | 39.85% | 103.71% | |
| 46Neutral | INR 42.80B | 24.88 | ― | 0.19% | 21.34% | 105.39% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:FAIRCHEMOR | Fairchem Organics Ltd | 653.70 | -17.09 | -2.55% | |
| IN:AARTIIND | AARTI Industries Ltd | 457.30 | 73.41 | 19.12% | |
| IN:ALKYLAMINE | Alkyl Amines Chemicals Limited | 1574.65 | -157.23 | -9.08% | |
| IN:ATUL | Atul Limited | 5063.35 | -882.84 | -14.85% | |
| IN:JUBLINGREA | Jubilant Ingrevia Ltd. | 573.90 | -140.88 | -19.71% | |
| IN:LXCHEM | Laxmi Organic Industries Ltd. | 154.00 | -28.49 | -15.61% |
Fairchem Organics Ltd Corporate Events
Fairchem Organics Confirms Full Demat Compliance Under SEBI Rules
Fairchem Organics Ltd has reported to the NSE and BSE that it has obtained the required confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The filing...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 14, 2026
